Yongan Tang
Overview
Explore the profile of Yongan Tang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
621
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang Y, Bordawekar I, Zaczek A, Vogt A
J Pharm Sci
. 2025 Mar;
114(5):103720.
PMID: 40049320
In the pharmaceutical industry, amorphous solid dispersions (ASDs) are commonly utilized to enhance the solubility and bioavailability of poorly soluble active pharmaceutical ingredients (APIs). Polymers such as copovidone are also...
2.
Xu X, Li T, Yang T, Liu F, Guo Z, Wu H, et al.
Nano Lett
. 2024 Sep;
24(39):12239-12248.
PMID: 39248330
Immunotherapy has revolutionized the cancer treatment paradigm, yet efficient immunotherapeutic responses against immune-cold/desert cancers remain challenging. Herein, we report that photoactivatable nanoagonists yield a potent antitumor synergy of photoimmunotherapy against...
3.
Liu F, Deng Y, Wang A, Yang T, Ke H, Tang Y, et al.
Expert Opin Drug Deliv
. 2024 Jun;
21(6):867-880.
PMID: 38913024
Introduction: Arsenicals have a special place in the history of human health, acting both as poison and medicine. Having been used to treat a variety of diseases in the past,...
4.
Li M, Yin S, Xu A, Kang L, Ma Z, Liu F, et al.
Pharmaceutics
. 2024 Jan;
16(1).
PMID: 38258044
Oral squamous cell carcinoma (OSCC) contributes to more than 90% of all oral malignancies, yet the performance of traditional treatments is impeded by limited therapeutic effects and substantial side effects....
5.
Lu X, Kulkarni S, Dong H, Tang Y, Yi L, Gupta S
Int J Pharm
. 2023 Mar;
636:122803.
PMID: 36894041
Low solid content and high fill drug product configuration pose special challenges for achieving elegant cake appearance after lyophilization. In this study, such a configuration for a protein formulation required...
6.
Li T, Zhang Y, Zhu J, Zhang F, Xu A, Zhou T, et al.
Adv Mater
. 2022 Dec;
35(14):e2210201.
PMID: 36573375
Artificial enzymes have demonstrated therapeutic benefits against diverse malignant tumors, yet their antitumor potencies are still severely compromised by non-selective catalysis, low atomic-utilization efficiency, and undesired off-target toxicity. Herein, it...
7.
Li T, Tan S, Li M, Luo J, Zhang Y, Jiang Z, et al.
Adv Mater
. 2022 Dec;
35(10):e2209603.
PMID: 36524741
Glutathione (GSH)-activatable probes hold great promise for in vivo cancer imaging, but are restricted by their dependence on non-selective intracellular GSH enrichment and uncontrollable background noise. Here, a holographically activatable...
8.
Mao P, Tang Y, Wang B, Fan D, Wang Y
ACS Appl Mater Interfaces
. 2022 May;
14(19):22295-22301.
PMID: 35533356
Recently, organic-inorganic hybrid scintillators have received more and more attention because of their merits of easy preparation, good stability, and nontoxicity. Considering the high cost of traditional inorganic scintillators, here...
9.
Dong X, Edmondson R, Yang F, Tang Y, Wang P, Sun Y, et al.
RSC Adv
. 2022 May;
10(56):33944-33954.
PMID: 35519058
The antiviral function of carbon dots (CDots) with visible light exposure was evaluated, for which the model bacteriophages MS2 as a surrogate of small RNA viruses were used. The results...
10.
Limbu T, Adhikari B, Song S, Chitara B, Tang Y, Parsons G, et al.
RSC Adv
. 2022 May;
11(61):38839-38848.
PMID: 35493247
Two-dimensional (2D) molybdenum ditelluride (MoTe) is an interesting material for fundamental study and applications, due to its ability to exist in different polymorphs of 2H, 1T, and 1T', their phase...